Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118006264 | 11800626 | 4 | F | 2003 | 20160713 | 20151204 | 20160719 | PER | US-AMGEN-USASL2015126891 | AMGEN | 43.00 | YR | A | M | Y | 0.00000 | 20160719 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118006264 | 11800626 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||||
| 118006264 | 11800626 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 3 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 4 | SS | COSENTYX | SECUKINUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 5 | SS | CLOBETASOL | CLOBETASOL | 1 | Unknown | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 6 | SS | TRIAMCINOLONE | TRIAMCINOLONE | 1 | Topical | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 7 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | UNK | 0 | ||||||||||
| 118006264 | 11800626 | 8 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118006264 | 11800626 | 1 | Psoriasis |
| 118006264 | 11800626 | 2 | Product used for unknown indication |
| 118006264 | 11800626 | 3 | Product used for unknown indication |
| 118006264 | 11800626 | 4 | Product used for unknown indication |
| 118006264 | 11800626 | 5 | Product used for unknown indication |
| 118006264 | 11800626 | 6 | Product used for unknown indication |
| 118006264 | 11800626 | 7 | Product used for unknown indication |
| 118006264 | 11800626 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118006264 | 11800626 | Drug effect decreased | |
| 118006264 | 11800626 | Drug ineffective | |
| 118006264 | 11800626 | Inflammation | |
| 118006264 | 11800626 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118006264 | 11800626 | 1 | 200301 | 0 | ||
| 118006264 | 11800626 | 4 | 2015 | 0 |